Skip to main content

and
  1. Article

    Open Access

    Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment

    Joseph Broucek, Tasha Hughes, Erica Huelsmann in Journal for ImmunoTherapy of Cancer (2014)

  2. No Access

    Article

    Therapy of bovine ocular squamous-cell carcinoma with local doses of interleukin-2: 67% complete regressions after 20 months of follow-up

    We have tested the therapeutic potency of peritumorally injected low doses of interleukin-2(IL-2). Seventy tumours of the bovine ocular squamous-cell carcinoma (BOSCC), 1–3 cm in diameter, were treated with 50...

    F. W. Willem Den Otter, Graham Hill, Wim R. Klein in Cancer Immunology, Immunotherapy (1995)